Tumor necrosis factor alpha-mediated joint destruction is inhibited by targeting osteoclasts with osteoprotegerin.
Redlich K, Hayer S, Maier A, Dunstan CR, Tohidast-Akrad M, Lang S, Türk B, Pietschmann P, Woloszczuk W, Haralambous S, Kollias G, Steiner G, Smolen JS, Schett G.
Redlich K, et al. Among authors: hayer s.
Arthritis Rheum. 2002 Mar;46(3):785-92. doi: 10.1002/art.10097.
Arthritis Rheum. 2002.
PMID: 11920416
Free article.